XML 32 R21.htm IDEA: XBRL DOCUMENT
v3.25.2

Segment Reporting | 6 Months Ended
--- | ---
Jun. 30, 2025
Segment Reporting [Abstract] |
Segment Reporting | Note 15. Segment Reporting Operating segments are defined as components of an entity for which discrete financial information is available that is regularly reviewed by the Chief Operating Decision Maker (“CODM”), who is the Chief Executive Officer, in deciding how to allocate resources to an individual segment and in assessing performance. The CODM reviews financial information for the purposes of making operating decisions, allocating resources, and evaluating financial performance of the business of the reportable operating segments, based on discrete financial information. The measures of segment profitability that are most relied upon by the CODM are gross revenues and net loss. The Company operates in two reportable business segments: (1) Dominari Financial and (2) Legacy AIkido. The Dominari Financial reportable business segment represents the Company’s broker-dealer business, which is composed of mostly underwriting and transactional service activities. The Legacy AIkido reportable business segment includes Dominari Labs (formerly Aikido Labs), which manages the investments holdings of the legacy entity. Prior to the FPS Acquisition, the Company operated as a single operating segment comprised of Legacy AIkido. The CODM has access to and regularly reviews internal financial reporting for each business and uses that information to make operational decisions and allocate resources. Accounting policies applied by the reportable segments are the same as those used by the Company and described in the “Summary of Significant Accounting Policies.” The measures of segment profitability that are most relied upon by the CODM are gross revenue and net loss, as presented within the table below and reconciled to the statement of operations. Additionally, the CODM views the expenses listed below to be significant in their analysis.
|  | Three Months Ended June 30, 2025 |
|  | Dominari Financial |  |  | Legacy AIkido Pharma |  |  | Consolidated |
Revenue |  | $ | 34,095 |  |  | $ | - |  |  | $ | 34,095 |
Operating Costs |  |  |  |  |  |  |  |  |  |  |  |
Compensation and benefits |  |  | 30,540 |  |  |  | 19,752 |  |  |  | 50,292 |
Professional and consulting fees |  |  | 711 |  |  |  | 495 |  |  |  | 1,206 |
Data processing |  |  | 177 |  |  |  | - |  |  |  | 177 |
Other (income)/expenses |  |  | (742 | ) |  |  | 2,588 |  |  |  | 1,846 |
Loss from operations |  |  | 3,409 |  |  |  | (22,835 | ) |  |  | (19,426 | )
Other (expenses) income |  |  |  |  |  |  |  |  |  |  |  |
Interest income |  |  | 364 |  |  |  | - |  |  |  | 364 |
Gain on marketable securities |  |  | 4,236 |  |  |  | 806 |  |  |  | 5,042 |
Change in fair value of investments |  |  | - |  |  |  | 31,680 |  |  |  | 31,680 |
Total other (expenses) income |  |  | 4,600 |  |  |  | 32,486 |  |  |  | 37,086 |
Net gain |  | $ | 8,009 |  |  | $ | 9,651 |  |  | $ | 17,660 |
Noncontrolling interests |  |  | 1,050 |  |  |  | - |  |  |  | 1,050 |
Net gain attributable to common stock holders of Dominari Holdings |  |  | 6,959 |  |  |  | 9,651 |  |  |  | 16,610 |
Total assets |  |  | 44,976 |  |  |  | 63,312 |  |  |  | 108,288 |
|  | Six Months Ended June 30, 2025 |
|  | Dominari |  |  | Legacy AIkido |  |  |  |
|  | Financial |  |  | Pharma |  |  | Consolidated |
Revenue |  | $ | 42,206 |  |  | $ | - |  |  | $ | 42,206 |
Operating Costs |  |  |  |  |  |  |  |  |  |  |  |
Compensation and benefits |  |  | 37,430 |  |  |  | 48,557 |  |  |  | 85,987 |
Professional and consulting fees |  |  | 1,358 |  |  |  | 1,269 |  |  |  | 2,627 |
Data processing |  |  | 359 |  |  |  | - |  |  |  | 359 |
Other expenses |  |  | 733 |  |  |  | 3,936 |  |  |  | 4,669 |
Loss from operations |  |  | 2,326 |  |  |  | (53,762 | ) |  |  | (51,436 | )
Other (expenses) income |  |  |  |  |  |  |  |  |  |  |  |
Interest income |  |  | 381 |  |  |  | 42 |  |  |  | 423 |
Gain on marketable securities |  |  | 3,326 |  |  |  | 638 |  |  |  | 3,964 |
Unrealized loss on note receivable |  |  | - |  |  |  | 221 |  |  |  | 221 |
Change in fair value of investments |  |  | - |  |  |  | 32,000 |  |  |  | 32,000 |
Total other (expenses) income |  |  | 3,707 |  |  |  | 32,901 |  |  |  | 36,608 |
Net loss |  | $ | 6,033 |  |  | $ | (20,861 | ) |  | $ | (14,828 | )
Noncontrolling interests |  |  | 1,050 |  |  |  | - |  |  |  | 1,050 |
Net gain attributable to common stock holders of Dominari Holdings |  |  | 4,983 |  |  |  | (20,861 | ) |  |  | (15,878 | )
Total assets |  |  | 44,976 |  |  |  | 63,312 |  |  |  | 108,288 |
|  | Three Months Ended June 30, 2024 |
|  | Dominari Financial |  |  | Legacy AIkido Pharma |  |  | Consolidated |
Revenue |  | $ | 5,503 |  |  | $ | 671 |  |  | $ | 6,174 |
Operating Costs |  |  |  |  |  |  |  |  |  |  |  |
Compensation and benefits |  |  | 4,962 |  |  |  | 1,725 |  |  |  | 6,687 |
Professional and consulting fees |  |  | 293 |  |  |  | 168 |  |  |  | 461 |
Data processing |  |  | 227 |  |  |  | 12 |  |  |  | 239 |
Other expenses |  |  | 847 |  |  |  | 676 |  |  |  | 1,523 |
Loss from operations |  |  | (826 | ) |  |  | (1,910 | ) |  |  | (2,736 | )
Other (expenses) income |  |  |  |  |  |  |  |  |  |  |  |
Interest income |  |  | 205 |  |  |  | 80 |  |  |  | 285 |
Gain on marketable securities |  |  | - |  |  |  | 104 |  |  |  | 104 |
Unrealized loss on note receivable |  |  | - |  |  |  | (742 | ) |  |  | (742 | )
Change in fair value of investments |  |  | - |  |  |  | (3,031 | ) |  |  | (3,031 | )
Total other (expenses) income |  |  | 205 |  |  |  | (3,589 | ) |  |  | (3,384 | )
Net loss |  | $ | (621 | ) |  | $ | (5,499 | ) |  | $ | (6,120 | )
Total assets |  |  | 17,361 |  |  |  | 31,712 |  |  |  | 49,073 |
|  | Six Months Ended June 30, 2024 |
|  | Dominari Financial |  |  | Legacy AIkido Pharma |  |  | Consolidated |
Revenue |  | $ | 6,870 |  |  | $ | 671 |  |  | $ | 7,541 |
Operating Costs |  |  |  |  |  |  |  |  |  |  |  |
Compensation and benefits |  |  | 6,384 |  |  |  | 2,452 |  |  |  | 8,836 |
Professional and consulting fees |  |  | 761 |  |  |  | 657 |  |  |  | 1,418 |
Data processing |  |  | 375 |  |  |  | 45 |  |  |  | 420 |
Other expenses |  |  | 1,370 |  |  |  | 1,038 |  |  |  | 2,408 |
Loss from operations |  |  | (2,020 | ) |  |  | (3,521 | ) |  |  | (5,541 | )
Other (expenses) income |  |  |  |  |  |  |  |  |  |  |  |
Interest income |  |  | 341 |  |  |  | 108 |  |  |  | 449 |
Gain on marketable securities |  |  | - |  |  |  | 678 |  |  |  | 678 |
Unrealized loss on note receivable |  |  | - |  |  |  | (1,657 | ) |  |  | (1,657 | )
Change in fair value of investments |  |  | - |  |  |  | (5,490 | ) |  |  | (5,490 | )
Total other (expenses) income |  |  | 341 |  |  |  | (6,361 | ) |  |  | (6,020 | )
Net loss |  | $ | (1,679 | ) |  | $ | (9,882 | ) |  | $ | (11,561 | )
Total assets |  |  | 17,361 |  |  |  | 31,712 |  |  |  | 49,073 |

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 15 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42 Reference 7: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 48 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 270 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (ee) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 11: http://fasb.org/us-gaap/role/ref/otherTransitionRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 12: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 13: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 14: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 15: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 16: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 17: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 34 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34 Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26C -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26B -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40 Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/280/tableOfContent Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26 Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration